United States Marine Derived Drugs Market Report & Forecast 2021-2027

Publisher Name :
Date: 20-Sep-2021
No. of pages: 92
Inquire Before Buying

United States Marine Derived Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

United States Marine Derived Drugs Market Segment Percentages, By Type, 2020 (%)

- Mollusk

- Sponge

- Tunicate

- Fish

- Others

United States Marine Derived Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

United States Marine Derived Drugs Market Segment Percentages, By Application, 2020 (%)

- Antitumor Drugs

- Anti-Cardiovascular Drugs

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Marine Derived Drugs revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Marine Derived Drugs revenues share in United States market, 2020 (%)

Key companies Marine Derived Drugs sales in United States market, 2016-2021 (Estimated), (K Units)

Key companies Marine Derived Drugs sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Seattle Genetics

- Eisai Co

- Tekada

- Pfizer

- Pharma Mar

- Johnson and Johnson

- GSK

- TerSera Therapeutics

- Teva

United States Marine Derived Drugs Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Marine Derived Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Marine Derived Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Marine Derived Drugs Overall Market Size
2.1 United States Marine Derived Drugs Market Size: 2021 VS 2027
2.2 United States Marine Derived Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Marine Derived Drugs Sales: 2016-2027
3 Company Landscape
3.1 Top Marine Derived Drugs Players in United States Market
3.2 Top United States Marine Derived Drugs Companies Ranked by Revenue
3.3 United States Marine Derived Drugs Revenue by Companies
3.4 United States Marine Derived Drugs Sales by Companies
3.5 United States Marine Derived Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Marine Derived Drugs Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Marine Derived Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Marine Derived Drugs Players in United States Market
3.8.1 List of Tier 1 Marine Derived Drugs Companies in United States
3.8.2 List of Tier 2 and Tier 3 Marine Derived Drugs Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Marine Derived Drugs Market Size Markets, 2021 & 2027
4.1.2 Mollusk
4.1.3 Sponge
4.1.4 Tunicate
4.1.5 Fish
4.1.6 Others
4.2 By Type - United States Marine Derived Drugs Revenue & Forecasts
4.2.1 By Type - United States Marine Derived Drugs Revenue, 2016-2021
4.2.2 By Type - United States Marine Derived Drugs Revenue, 2022-2027
4.2.3 By Type - United States Marine Derived Drugs Revenue Market Share, 2016-2027
4.3 By Type - United States Marine Derived Drugs Sales & Forecasts
4.3.1 By Type - United States Marine Derived Drugs Sales, 2016-2021
4.3.2 By Type - United States Marine Derived Drugs Sales, 2022-2027
4.3.3 By Type - United States Marine Derived Drugs Sales Market Share, 2016-2027
4.4 By Type - United States Marine Derived Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Marine Derived Drugs Market Size, 2021 & 2027
5.1.2 Antitumor Drugs
5.1.3 Anti-Cardiovascular Drugs
5.1.4 Others
5.2 By Application - United States Marine Derived Drugs Revenue & Forecasts
5.2.1 By Application - United States Marine Derived Drugs Revenue, 2016-2021
5.2.2 By Application - United States Marine Derived Drugs Revenue, 2022-2027
5.2.3 By Application - United States Marine Derived Drugs Revenue Market Share, 2016-2027
5.3 By Application - United States Marine Derived Drugs Sales & Forecasts
5.3.1 By Application - United States Marine Derived Drugs Sales, 2016-2021
5.3.2 By Application - United States Marine Derived Drugs Sales, 2022-2027
5.3.3 By Application - United States Marine Derived Drugs Sales Market Share, 2016-2027
5.4 By Application - United States Marine Derived Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Seattle Genetics
6.1.1 Seattle Genetics Corporation Information
6.1.2 Seattle Genetics Overview
6.1.3 Seattle Genetics Marine Derived Drugs Sales and Revenue in United States Market (2016-2021)
6.1.4 Seattle Genetics Marine Derived Drugs Product Description
6.1.5 Seattle Genetics Recent Developments
6.2 Eisai Co
6.2.1 Eisai Co Corporation Information
6.2.2 Eisai Co Overview
6.2.3 Eisai Co Marine Derived Drugs Sales and Revenue in United States Market (2016-2021)
6.2.4 Eisai Co Marine Derived Drugs Product Description
6.2.5 Eisai Co Recent Developments
6.3 Tekada
6.3.1 Tekada Corporation Information
6.3.2 Tekada Overview
6.3.3 Tekada Marine Derived Drugs Sales and Revenue in United States Market (2016-2021)
6.3.4 Tekada Marine Derived Drugs Product Description
6.3.5 Tekada Recent Developments
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Overview
6.4.3 Pfizer Marine Derived Drugs Sales and Revenue in United States Market (2016-2021)
6.4.4 Pfizer Marine Derived Drugs Product Description
6.4.5 Pfizer Recent Developments
6.5 Pharma Mar
6.5.1 Pharma Mar Corporation Information
6.5.2 Pharma Mar Overview
6.5.3 Pharma Mar Marine Derived Drugs Sales and Revenue in United States Market (2016-2021)
6.5.4 Pharma Mar Marine Derived Drugs Product Description
6.5.5 Pharma Mar Recent Developments
6.6 Johnson and Johnson
6.6.1 Johnson and Johnson Corporation Information
6.6.2 Johnson and Johnson Overview
6.6.3 Johnson and Johnson Marine Derived Drugs Sales and Revenue in United States Market (2016-2021)
6.6.4 Johnson and Johnson Marine Derived Drugs Product Description
6.6.5 Johnson and Johnson Recent Developments
6.7 GSK
6.7.1 GSK Corporation Information
6.7.2 GSK Overview
6.7.3 GSK Marine Derived Drugs Sales and Revenue in United States Market (2016-2021)
6.7.4 GSK Marine Derived Drugs Product Description
6.7.5 GSK Recent Developments
6.8 TerSera Therapeutics
6.8.1 TerSera Therapeutics Corporation Information
6.8.2 TerSera Therapeutics Overview
6.8.3 TerSera Therapeutics Marine Derived Drugs Sales and Revenue in United States Market (2016-2021)
6.8.4 TerSera Therapeutics Marine Derived Drugs Product Description
6.8.5 TerSera Therapeutics Recent Developments
6.9 Teva
6.9.1 Teva Corporation Information
6.9.2 Teva Overview
6.9.3 Teva Marine Derived Drugs Sales and Revenue in United States Market (2016-2021)
6.9.4 Teva Marine Derived Drugs Product Description
6.9.5 Teva Recent Developments
7 United States Marine Derived Drugs Production Capacity, Analysis
7.1 United States Marine Derived Drugs Production Capacity, 2016-2027
7.2 Marine Derived Drugs Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Marine Derived Drugs Supply Chain Analysis
9.1 Marine Derived Drugs Industry Value Chain
9.2 Marine Derived Drugs Upstream Market
9.3 Marine Derived Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Marine Derived Drugs Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Marine Derived Drugs in United States Market
Table 2. Top Marine Derived Drugs Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Marine Derived Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Marine Derived Drugs Revenue Share by Companies, 2016-2021
Table 5. United States Marine Derived Drugs Sales by Companies, (K Units), 2016-2021
Table 6. United States Marine Derived Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Marine Derived Drugs Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Marine Derived Drugs Product Type
Table 9. List of Tier 1 Marine Derived Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Marine Derived Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Mollusk
Table 12. Major Manufacturers of Sponge
Table 13. By Type - United States Marine Derived Drugs Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Marine Derived Drugs Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Marine Derived Drugs Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Marine Derived Drugs Sales (K Units), 2016-2021
Table 17. By Type - United States Marine Derived Drugs Sales (K Units), 2022-2027
Table 18. By Application - United States Marine Derived Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Marine Derived Drugs Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Marine Derived Drugs Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Marine Derived Drugs Sales (K Units), 2016-2021
Table 22. By Application - United States Marine Derived Drugs Sales (K Units), 2022-2027
Table 23. Seattle Genetics Corporation Information
Table 24. Seattle Genetics Description and Major Businesses
Table 25. Seattle Genetics Marine Derived Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Seattle Genetics Marine Derived Drugs Product
Table 27. Seattle Genetics Recent Developments
Table 28. Eisai Co Corporation Information
Table 29. Eisai Co Description and Major Businesses
Table 30. Eisai Co Marine Derived Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Eisai Co Marine Derived Drugs Product
Table 32. Eisai Co Recent Developments
Table 33. Tekada Corporation Information
Table 34. Tekada Description and Major Businesses
Table 35. Tekada Marine Derived Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Tekada Marine Derived Drugs Product
Table 37. Tekada Recent Developments
Table 38. Pfizer Corporation Information
Table 39. Pfizer Description and Major Businesses
Table 40. Pfizer Marine Derived Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Pfizer Marine Derived Drugs Product
Table 42. Pfizer Recent Developments
Table 43. Pharma Mar Corporation Information
Table 44. Pharma Mar Description and Major Businesses
Table 45. Pharma Mar Marine Derived Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Pharma Mar Marine Derived Drugs Product
Table 47. Pharma Mar Recent Developments
Table 48. Johnson and Johnson Corporation Information
Table 49. Johnson and Johnson Description and Major Businesses
Table 50. Johnson and Johnson Marine Derived Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Johnson and Johnson Marine Derived Drugs Product
Table 52. Johnson and Johnson Recent Developments
Table 53. GSK Corporation Information
Table 54. GSK Description and Major Businesses
Table 55. GSK Marine Derived Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. GSK Marine Derived Drugs Product
Table 57. GSK Recent Developments
Table 58. TerSera Therapeutics Corporation Information
Table 59. TerSera Therapeutics Description and Major Businesses
Table 60. TerSera Therapeutics Marine Derived Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. TerSera Therapeutics Marine Derived Drugs Product
Table 62. TerSera Therapeutics Recent Developments
Table 63. Teva Corporation Information
Table 64. Teva Description and Major Businesses
Table 65. Teva Marine Derived Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Teva Marine Derived Drugs Product
Table 67. Teva Recent Developments
Table 68. Marine Derived Drugs Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 69. United States Marine Derived Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Marine Derived Drugs Market Opportunities & Trends in United States Market
Table 71. Marine Derived Drugs Market Drivers in United States Market
Table 72. Marine Derived Drugs Market Restraints in United States Market
Table 73. Marine Derived Drugs Raw Materials
Table 74. Marine Derived Drugs Raw Materials Suppliers in United States Market
Table 75. Typical Marine Derived Drugs Downstream
Table 76. Marine Derived Drugs Downstream Clients in United States Market
Table 77. Marine Derived Drugs Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Marine Derived Drugs Product Picture
Figure 2. Marine Derived Drugs Segment by Type
Figure 3. Marine Derived Drugs Segment by Application
Figure 4. United States Marine Derived Drugs Market Overview: 2020
Figure 5. United States Marine Derived Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Marine Derived Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Marine Derived Drugs Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Marine Derived Drugs Revenue in 2020
Figure 9. Mollusk Product Picture
Figure 10. Sponge Product Picture
Figure 11. Tunicate Product Picture
Figure 12. Fish Product Picture
Figure 13. Others Product Picture
Figure 14. By Type - United States Marine Derived Drugs Sales Market Share, 2016-2027
Figure 15. By Type - United States Marine Derived Drugs Revenue Market Share, 2016-2027
Figure 16. By Type - United States Marine Derived Drugs Price (USD/Unit), 2016-2027
Figure 17. Antitumor Drugs
Figure 18. Anti-Cardiovascular Drugs
Figure 19. Others
Figure 20. By Application - United States Marine Derived Drugs Sales Market Share, 2016-2027
Figure 21. By Application - United States Marine Derived Drugs Revenue Market Share, 2016-2027
Figure 22. By Application - United States Marine Derived Drugs Price (USD/Unit), 2016-2027
Figure 23. Seattle Genetics Marine Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Eisai Co Marine Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Tekada Marine Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Pfizer Marine Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Pharma Mar Marine Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Johnson and Johnson Marine Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. GSK Marine Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. TerSera Therapeutics Marine Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Teva Marine Derived Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. United States Marine Derived Drugs Production Capacity (K Units), 2016-2027
Figure 33. Marine Derived Drugs Industry Value Chain
Figure 34. Marketing Channels
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs